Black Diamond Therapeutics Announces Pricing of Initial Public Offering By Araceli Richardson|2020-08-18T00:57:30-07:00January 29, 2020|
Black Diamond Therapeutics Closes $85 Million Series C Financing By Araceli Richardson|2020-08-18T00:57:30-07:00December 5, 2019|
Boundless Bio Launches to Deliver Transformative Therapies to Patients with Difficult-to-Treat Cancers Driven by Extrachromosomal DNA By Araceli Richardson|2020-08-18T00:57:30-07:00September 19, 2019|
FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor By Araceli Richardson|2020-08-18T00:57:30-07:00August 15, 2019|
ORIC Pharmaceuticals Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance By Araceli Richardson|2020-08-18T00:57:31-07:00August 8, 2019|
Japan becomes the first country to approve Roche’s personalised medicine Rozlytrek By Araceli Richardson|2020-08-18T00:57:31-07:00June 18, 2019|
OncoMyx Therapeutics Completes $25 Million Series A Financing By Araceli Richardson|2020-08-18T00:57:31-07:00June 5, 2019|
Inhibrx Announces $40M Investment from Viking Global Investors By Araceli Richardson|2020-08-18T00:57:31-07:00May 21, 2019|
Erasca™ Announces Series A Extension, Bringing Total Round to $64 Million By Araceli Richardson|2020-08-18T00:57:31-07:00March 5, 2019|
Maze Therapeutics Launches with $191 Million to Focus on Translating Genetic Insights into New Medicines By Araceli Richardson|2020-08-18T00:57:31-07:00February 28, 2019|
